Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

AbbVie (ABBV) : "I like AbbVie. I think it's a buy."

Greendot (GDOT) : "I think of this one as financial tech and I like it."

Sherwin-Williams (SHW) : "Sherwin-Williams is a good one."

Visteon (VC) : "I think you have to be careful with this one."

TransEnterix (TRXC) : "I like Intuitive Surgical (ISRG) . I say stick with ISRG."

Duke Energy (DUK) : "I don't want to be in Duke, I want American Electric Power (AEP) and Consolidated Edison (ED) ."

Buckeye Partners (BPL) : "I've soured on the pipeline group. They're too hit or miss."

Axon Enterprise (AAXN) : "This is heavily shorted, but I think it's a buy. "

Arch Coal (ARCH) : "I'm not a fan of the coal stocks. Utilities aren't interested in coal."

Apptio (APTI) : "I'd like to have these guys on the show."

Cramer and the AAP team are updating their core holdings and have notes from their monthly members-only call. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Over on Real Money, Cramer says explains why shorting's been such a bust. Get more of his insights with a free trial subscription to Real Money.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in ABBV.

More from Jim Cramer

Gilead Sciences, KeyCorp, Ventas: 'Mad Money' Lightning Round

Gilead Sciences, KeyCorp, Ventas: 'Mad Money' Lightning Round

Is the Fed on Course?: Cramer's 'Mad Money' Recap (Wednesday 10/17/18)

Is the Fed on Course?: Cramer's 'Mad Money' Recap (Wednesday 10/17/18)

Jim Cramer Dives Into Cannabis and IBM Earnings

Jim Cramer Dives Into Cannabis and IBM Earnings

Wednesday Wrap-Up: The Talk of the Town Is Cannabis

Wednesday Wrap-Up: The Talk of the Town Is Cannabis

Jim Cramer: Is the Fed Right With Its Current Course of Raising Rates?

Jim Cramer: Is the Fed Right With Its Current Course of Raising Rates?